500 mg NAD+ vial: Add 5 mL 100 mg/mL
This triple-agonist approach, targeting GLP-1, GIP, and glucagon receptors, produced the most dramatic weight loss results seen in any Phase 2 obesity trial
The broader discussion of peptides for chronic pain conditions may also be relevant for individuals managing complex pain presentations during fracture recovery
Experimental performance: MJH, HTL, HYH, and YL
Proper storage practices are discussed in greater detail in our guide to How to Store Research Peptides: Stability, Temperature & Shelf Life, which covers refrigeration, freezing, transportation, and long-term handling considerations for a wide range of research peptides